PROVIDER PROFILE · NPI 1942497359

Mario PinedaM.D./PH.D.

PRACTICEIRONWOOD PHYSICIANS, PCSee all providers at this practice →

Gynecological OncologyChandler, AZI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

262

Unique beneficiaries

—

Total services

512

Distinct HCPCS

Medicare payment

$46K

Peer benchmark

Total Medicare services vs. 19 Gynecological Oncology providers in AZ — above median (cohort median 1,157).

PRESCRIBING · PART D · 2024

Total Rx claims

275

Beneficiaries

—

Total drug cost

$365K

Distinct drugs

Brand share

56.0%

Top prescribed drugs

Dexamethasone46 claims

Ondansetron37 claims

Oxycodone Hcl/Acetaminophen33 claims

Hydrocodone/Acetaminophen27 claims

Rivaroxaban25 claims

QUALITY · MIPS · 2024

Final MIPS score

97.2

Quality

96.0

Cost

56.7

Improvement activities

40.0

Promoting interop.

98.0

Payment adjustment

0.93%

Subgroup

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$941

Payment records

By payment type

Food and Beverage$941

REFERRAL NETWORK

Where Mario Pineda's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NORTHWESTERN MEMORIAL HEALTHCARE	100	1,091
William Gradishar Medical Oncology · Chicago, IL	19	57
Emily Berry Gynecological Oncology · Bend, OR	18	144
Nancy Anderson Nurse Practitioner · Chicago, IL	14	107

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history